AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesTechnology, Industry, Agriculture
GlucoseAbsorptionBlood GlucoseKidney Tubules, ProximalKidney TubulesGlucose Tolerance TestKidney Tubules, DistalSodiumGlucose IntoleranceKidneyNephronsInulinLoop of HenleBicarbonatesGlomerular Filtration RateGlucose OxidaseGlucose Transporter Type 1NatriuresisDiuresisPuncturesGlucose Transporter Type 4Kidney Tubules, CollectingBiological TransportWater-Electrolyte BalanceKidney Concentrating AbilityMonosaccharide Transport ProteinsSodium ChlorideChlorothiazidePhlorhizinAminohippuric AcidsInsulinBlood Glucose Self-MonitoringGlycosuriaSodium-Glucose Transporter 2Glucose 1-DehydrogenaseAlkalosisEjaculatory DuctsDeoxyglucosePotassiumFurosemideGlucose Transporter Type 2Biological Transport, ActiveEpithelial Sodium ChannelsPhosphatesPerfusionLow Density Lipoprotein Receptor-Related Protein-2Solute Carrier Family 12, Member 1FastingRats, Sprague-DawleyHypoglycemic AgentsKidney CortexSodium-Glucose Transporter 1Kidney MedullaOsmolar ConcentrationGlucose Transporter Type 3Diabetes Mellitus, Type 2DiureticsRats, WistarLithiumGlycogenAmilorideHomeostasisAquaporin 2DogsBody WaterBody FluidsGlucagonRats, Inbred StrainsAcid-Base EquilibriumSodium-Phosphate Cotransporter ProteinsGlucose DehydrogenasesAldosteroneSymportersExtracellular SpaceSodium Chloride SymportersGlycolysisGluconeogenesisCalcium Metabolism DisordersSodium-Hydrogen AntiporterAcetazolamideChloridesIslets of LangerhansMannitolFructoseMicrovilliLactatesKineticsIsotonic SolutionsHypoglycemiaCarbonic Anhydrase InhibitorsElectrolytesLactic AcidHydrogen-Ion ConcentrationTime FactorsWaterSodium-Phosphate Cotransporter Proteins, Type IIaSodium-Potassium-Chloride SymportersHexokinaseGlucose-6-PhosphateGlucokinase
SGLT2UrineKidneysInhibitorsAmino acidsProximal tubuleInhibitorInsulinHepatic glucose productionKidneyUric acidPhosphateBicarbonateLower blood glucoseSGLTTransporterUrinaryDecreasesIntestinal absorption of glucosePlasma glucoseEmpagliflozinConcentrationsUptakeBody'sRenal glucoseReduce blood glucoseReduces blood glucoseDistalAbsorptionType 2 diabetSodium and glucoseLevelsMetabolismPostprandialTransportersMedicationsSubstancesTolerance
SGLT234
  • Firstly, the glucose in the proximal tubule is co-transported with sodium ions into the proximal convoluted tubule walls via the SGLT2 cotransporter. (wikipedia.org)
  • Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a unique class of oral antidiabetic medications that reduce glucose reabsorption in the renal proximal tubules, thereby enhancing urinary glucose excretion 1 . (nature.com)
  • Euglycemic diabetic ketoacidosis (EDKA) is a potentially life-threatening condition and a reported side effect of antidiabetic sodium-glucose-cotransporter-2-inhibitors (SGLT2-I). The analysis of the herein presented case and its management formed the incentive to prepare this multidisciplinary work and includes an overview about perioperative SGLT2-I-induced ketoacidosis. (frontiersin.org)
  • Sodium-glucose cotransporter-2 inhibitors (SGLT2-I) are a modern drug class within the horizon of antidiabetic management. (frontiersin.org)
  • Dapagliflozin is a sodium- glucose cotransporter (SGLT2) inhibitor. (medicinenet.com)
  • SGLT2 is found in the kidney tubules and is responsible for reabsorbing the majority of glucose filtered out of the blood by the kidneys. (medicinenet.com)
  • By inhibiting SGLT2 dapagliflozin reduces the reabsorption of filtered glucose and consequently increases excretion of glucose in the urine. (medicinenet.com)
  • Glucose reabsorption in the proximal tubule (via Sglt1 and Sglt2) has emerged as an important contributor to the development of diabetes. (nih.gov)
  • Sodium-glucose transport protein 2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes. (healthline.com)
  • SGLT2 inhibitors prevent the reabsorption of glucose from blood that's filtered through your kidneys, therefore facilitating glucose excretion in the urine. (healthline.com)
  • SGLT2 inhibitors lead to a reduction in plasma glucose by inhibiting renal tubular glucose reabsorption, with resultant glucosuria. (ccs.ca)
  • The SGLT2 inhibitor empagliflozin was the first glucose-lowering drug to show an improvement in cardiovascular outcomes in a large randomized controlled clinical trial. (ccs.ca)
  • Empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor, removes excess glucose through the urine by blocking glucose re-absorption in the kidney. (centerwatch.com)
  • Synjardy is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin, a biguanide. (centerwatch.com)
  • Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. (centerwatch.com)
  • By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. (centerwatch.com)
  • Sotagliflozin inhibits sodium-glucose cotransporter 1 (SGLT1) and sodium-glucose cotransporter 2 (SGLT2). (pharmacytimes.com)
  • SGLT2 inhibition reduces renal reabsorption of glucose and sodium, which may lower both preload and afterload of the heart and downregulate sympathetic activity. (pharmacytimes.com)
  • Sodium/glucose cotransporter 2 (SGLT2) is the predominant mediator of renal glucose reabsorption and is an emerging molecular target for the treatment of diabetes. (aspetjournals.org)
  • These findings demonstrate that tofogliflozin inhibits SGLT2 in a specific manner, lowers blood glucose levels by increasing renal glucose clearance, and improves pathological conditions of type 2 diabetes with a low hypoglycemic potential. (aspetjournals.org)
  • Approximately 10% of renal glucose re-absorption occurs via SGLT1, and the remaining 90% occurs via SGLT2, which is found in the early proximal tubule. (bjcardio.co.uk)
  • SGLT2, a high-capacity, low-affinity transporter of glucose and sodium is found in high concentration at the brush border membrane of the S1 and S2 segment of the proximal convoluted tubule (PCT). (bjcardio.co.uk)
  • SGLT2 binds to sodium and glucose in the filtrate and these compounds are translocated across the apical cell membrane, an active process driven by the electrochemical sodium gradient between tubular filtrate and the cell. (bjcardio.co.uk)
  • INVOKANA™ is the first in a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors to be approved in the United States. (jnj.com)
  • An important carrier responsible for this reabsorption is called sodium glucose co-transporter 2 (SGLT2). (jnj.com)
  • INVOKANA™ selectively inhibits SGLT2, and as a result promotes the loss of glucose in the urine, lowering blood glucose levels in adults with type 2 diabetes. (jnj.com)
  • It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor which works by lowering the amount of sugar that the body absorbs by having the body secrete extra sugar through the urine. (diabetesdaily.com)
  • Clinical interest in the management of type 2 diabetes in the presence of HF has grown with the publication of cardiovascular outcomes trials (CVOTs) for sodium-glucose cotransporter 2 (SGLT2) inhibitors demonstrating HF-related benefits and other trials showing heightened risk with the use of certain other antihyperglycemic therapies. (diabetesjournals.org)
  • The two components of the therapy have very different modes of action: empagliflozin is a sodium glucose co-transporter-2 (SGLT2) inhibitor that removes excess glucose through the urine by blocking glucose reabsorption in the kidney, while metformin decreases the production of glucose in the liver and its absorption in the intestine and improves the body's ability to utilise glucose. (pharmatimes.com)
  • SGLT1 reabsorbs glucose in the gastrointestinal tract, while SGLT2 reabsorbs it in the kidney. (ajmc.com)
  • Zynquista's dual mechanism of action provides important treatment benefits for adults with type 1 diabetes, including reducing blood sugar reabsorption in the kidneys through SGLT2 inhibition and delaying dietary sugar absorption through local SGLT1 inhibition in the intestinal tract," said John Reed, MD, PhD, global head of research and development, Sanofi, in a statement . (ajmc.com)
  • The anti-diabetic action is through the competitive inhibition of the sodium-dependent blood transporters (SGLT1 and SGLT2) of metabolites such as glucose (Ehrenkranz et al. (aphios.com)
  • DPP-4 inhibitors work through a similar mechanism and have the same effects as GLP1 receptor agonists, he added, while SGLT2 inhibitors block the reabsorption of glucose from the kidneys. (benefitscanada.com)
  • SGLT2 inhibitors: These drugs block the reabsorption of glucose by the kidneys, which helps to lower blood glucose levels. (spagati.com)
Urine20
  • Renal glucose reabsorption is the part of kidney (renal) physiology that deals with the retrieval of filtered glucose, preventing it from disappearing from the body through the urine. (wikipedia.org)
  • If glucose is not reabsorbed by the kidney, it appears in the urine, in a condition known as glycosuria. (wikipedia.org)
  • However, no glucose is found in healthy urine as the glucose is reabsorbed in the nephron. (albertteen.com)
  • How much glucose is in healthy urine? (albertteen.com)
  • The diagnosis of Fanconi syndrome is made based on tests that document the excessive loss of substances in the urine (eg, amino acids, glucose, phosphate, bicarbonate) in the absence of high plasma concentrations. (medscape.com)
  • More elaborate tests are designed to determine the renal threshold for these substances (ie, the concentration in the blood at which these substances appear in the urine) or their fractional reabsorption (ie, the percentage of the filtered load that is reabsorbed by the renal tubule). (medscape.com)
  • In situations such as blood sugar highs in diabetics we can see glucose in the urine as a coping mechanism to bring blood glucose levels down, but that situation is bad, bad business. (robbwolf.com)
  • 4-Glucose in the urine: Five Alarm No Bueno. (robbwolf.com)
  • INVOKANA™ is thought to work differently than other currently-available medicines because it reduces blood glucose by acting on the kidneys as a 'glucuretic,' increasing the loss of glucose in the urine. (jnj.com)
  • What has historically been viewed as a sign of diabetes - glucose in the urine - may also reflect the efficacy of a new and unique approach to treatment. (jnj.com)
  • SGLT-2 inhibitors help patients achieve improved glycaemic control by reducing the reabsorption of glucose from the blood and enabling its removal via the urine. (diabetesdaily.com)
  • Lilly said the treatment, a once-daily tablet named empagliflozin, belongs to a class of drugs that aim to reduce blood sugar levels in patients by blocking glucose reabsorption in the kidney and removing excess glucose through urine. (ibj.com)
  • The urine primarily formed contains a high concentration of glucose, which is returned to the main blood stream by means of the carrier molecules. (indianetzone.com)
  • Urine is produced through the three processes of filtration, reabsorption, and tubular secretion. (indianetzone.com)
  • Besides maintaining the production of urine and urinary secretion, it also responsible for a number of other homoeostatic functions including re-absorption of glucose, amino acids, and production of hormones. (worldwidehealth.com)
  • SGLT-2 inhibitors, like canagliflozin ( Invokana ), lower the body's rate of reabsorption of filtered glucose, leading to an increase of glucose excretion through the urine. (rxwiki.com)
  • This drug blocks that process so more glucose is secreted in the urine that brings blood sugar down, but only when blood sugar levels begin to rise, said Hotchkiss. (benefitscanada.com)
  • In renal glucosuria, glucose (sugar) is excreted in the urine, despite normal or low glucose levels in the blood. (msdmanuals.com)
  • In people with renal glucosuria, glucose may be excreted in the urine despite normal or low levels of glucose in the blood. (msdmanuals.com)
  • A doctor makes the diagnosis when a routine urine test detects glucose in the urine even though glucose levels in the blood are normal. (msdmanuals.com)
Kidneys8
  • Sodium increases because low blood volume is a stimulus for an increase in sodium reabsorption in the kidneys. (livestrong.com)
  • diabetes is also associated with excess urination because the concentration of blood glucose exceeds the kidneys' capacity for glucose reabsorption. (livestrong.com)
  • The kidneys make an important contribution to balancing blood glucose. (jnj.com)
  • As glucose is filtered from the blood into the kidneys, it is reabsorbed back into the bloodstream. (jnj.com)
  • SGLT-2i reduce reabsorption of glucose from the kidneys thereby promoting glucosuria, while their beneficial effects on insulin resistance have been recently recognized. (endocrine-abstracts.org)
  • When blood glucose levels begin to go up, the kidneys normally filter out glucose but reabsorb it. (benefitscanada.com)
  • In most healthy people, glucose that is filtered from the blood by the kidneys is completely reabsorbed back into the blood. (msdmanuals.com)
  • The kidneys also reabsorb glucose and amino acids and have hormonal functions via erythropoietin, calcitriol, and vitamin D activation. (medscape.com)
Inhibitors4
  • Sodium-glucose cotransporter 2 inhibitors (SGLT2i) represent a relatively new class of oral glucose-lowering agents that reduce adverse cardiovascular and kidney outcomes among individuals with chronic kidney disease (CKD). (lww.com)
  • In recent randomized controlled clinical trials, medications within the sodium-glucose cotransporter (SGLT) 2 inhibitors (SGLT2i) class have shown improvements in adverse cardiovascular and kidney outcomes among individuals with CKD [7▪▪,8,9▪▪,10▪] . (lww.com)
  • 2 Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the newest class of oral diabetes medications. (uspharmacist.com)
  • DPP-4 inhibitors reduce blood glucose as measured by HbA1c. (diabetesdaily.com)
Amino acids5
  • Once in the tubule wall, the glucose and amino acids diffuse directly into the blood capillaries along a concentration gradient. (wikipedia.org)
  • Under the scenario of a defective cellular energy metabolism, any process that results in a decrease in the level of ATP impairs the performance of secondary active transport mechanisms, such as those of glucose, phosphate, or amino acids. (medscape.com)
  • Fanconi syndrome is due to dysfunction of the renal proximal tubule resulting in the urinary loss of substances normally reabsorbed by the kidney at this site, such as bicarbonate, glucose, amino acids, phosphate, small proteins, and uric acid. (bmj.com)
  • Tubules are long structures right off the approximately 1.5 million filtering units of the kidney, where resorption of things like water, glucose and amino acids also happen, and which pass waste along to the bladder for elimination. (eurekalert.org)
  • Fanconi Syndrome Fanconi syndrome is a rare disorder of kidney tubule function that results in excess amounts of glucose, bicarbonate, phosphates (phosphorus salts), uric acid, potassium, and certain amino acids. (msdmanuals.com)
Proximal tubule4
  • Numerous mechanisms can result in diminished reabsorption of solutes by the proximal tubule. (medscape.com)
  • Olfactory receptor 1393 (Olfr1393) was recently identified as a novel regulator of Na + -glucose cotransporter 1 (Sglt1) localization in the renal proximal tubule. (nih.gov)
  • We hypothesized that Olfr1393 may contribute to the progression of type 2 diabetes, particularly the development of hyperfiltration, which has been linked to increased Na + reabsorption in the proximal tubule via the Sglts. (nih.gov)
  • Collectively, these data indicate that renal Olfr1393 can contribute to the progression of type 2 diabetes, likely as a regulator of Na + -glucose cotransport in the proximal tubule. (nih.gov)
Inhibitor1
  • Empagliflozin, a sodium-glucose co-transporter 2 inhibitor developed, has been shown to reduce cardiovascular events in patients with type 2 diabetes and established cardiovascular disease. (nature.com)
Insulin17
  • Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. (centerwatch.com)
  • Diabetic patients, especially those on insulin, may not recognize symptoms as DKA because the serum glucose is not elevated. (uspharmacist.com)
  • 5 Low plasma glucose concentrations, in turn, create a carbohydrate deficit and volume depletion, stimulating glucagon secretion and suppressing insulin production. (uspharmacist.com)
  • Furthermore, no interaction with tofogliflozin was observed in any of a battery of tests examining glucose-related physiological processes, such as glucose uptake, glucose oxidation, glycogen synthesis, hepatic glucose production, glucose-stimulated insulin secretion, and glucosidase reactions. (aspetjournals.org)
  • They inhibit glucose re-absorption in the proximal renal tubules providing an insulin independent mechanism to lower blood glucose. (bjcardio.co.uk)
  • Treatment with traditional glucose-lowering therapies, including metformin, sulphonylureas and insulin, is commonly limited by gastrointestinal side effects, weight gain and hypoglycaemia. (bjcardio.co.uk)
  • These work independently of insulin to prevent glucose re-absorption from the glomerular filtrate resulting in a reduced renal threshold for glucose, glycosuria and net calorie loss ( figure 1 ). (bjcardio.co.uk)
  • INVOKANA™ has been studied as a single agent (monotherapy), in combination with metformin, and in combination with other glucose-lowering agents, including insulin, in patients who need further glucose control. (jnj.com)
  • Your blood sugar (also called blood glucose) levels may be high if your pancreas is producing little or no insulin ( type 1 diabetes ), or if the body is not responding normally to insulin ( type 2 diabetes ). (webmd.com)
  • This is because adequate amounts of dietary fibre may help with weight management by slowing down digestion (keeping us fuller for longer) and helping the release of glucose and insulin. (bbcgoodfood.com)
  • In type 2 diabetes, the body does not use the hormone insulin (which helps the body use glucose for energy) properly, resulting in high blood glucose levels. (rxwiki.com)
  • When blood glucose levels begin to drop, a sulphonylurea will tell the pancreas to continue to produce more insulin, he said, which can cause blood glucose levels to dip into hypoglycemic range. (benefitscanada.com)
  • Another older class of medication, Metformin, decreases the liver's glucose production and increases sensitivity to the effects of insulin, he added, noting Metformin has had a long track record of safety - it doesn't cause hypoglycemia and is the first-line treatment for those with type 2 diabetes. (benefitscanada.com)
  • In people with diabetes, the body's ability to utilize or produce insulin, a hormonal agent that helps to manage blood glucose levels, suffers american diabetes association connecticut. (spagati.com)
  • A hormone called insulin is in charge of assisting in the entry of food-derived glucose into cells for cellular energy utilization. (spagati.com)
  • GLP-1 receptor agonists: These drugs help to slow down the absorption of glucose from the stomach and boost insulin production. (spagati.com)
  • Diabetes Mellitus (DM) Diabetes mellitus is a disorder in which the body does not produce enough or respond normally to insulin, causing blood sugar (glucose) levels to be abnormally high. (msdmanuals.com)
Hepatic glucose production1
  • 1 Other factors that can contribute to EDKA are 1) the decrease in hepatic glucose production during a fasting state when glycogen stores are already depleted and 2) the increased urinary excretion of glucose. (uspharmacist.com)
Kidney6
Uric acid1
Phosphate2
  • SGLT2i may alter renal tubular phosphate reabsorption and are associated with increased serum concentrations of phosphate, fibroblast growth factor-23 (FGF-23), parathyroid hormone (PTH), decreased 1,25-hydroxyvitamin D levels, as well as increased bone turnover. (lww.com)
  • In addition, a renal tubular defect that reduces reabsorption may alter phosphate metabolism. (medscape.com)
Bicarbonate3
  • The term renal tubular acidosis (RTA) describes a group of disorders of acid-base homeostasis, in which the primary impairment is the excretion of fixed acid (distal RTA) or the reabsorption of filtered bicarbonate (proximal RTA). (bmj.com)
  • The proximal convoluted tubule (PCT) is the major site for reabsorption of filtered bicarbonate. (medscape.com)
  • In proximal RTA (pRTA), bicarbonate reabsorption is defective. (medscape.com)
Lower blood glucose1
SGLT2
  • Since the mid-1960s, it has been known that there are energy-dependent, sodium-coupled glucose transporter (SGLT) and energy-independent, facilitative glucose transporter (GLUT) pathways for glucose uptake in the lung [ 1 ], and that glucose can permeate the alveolar epithelial barrier [ 2 ]. (ersjournals.com)
  • However, much subsequent research in this area was focused on the role of pulmonary SGLT transport as a modifier of lung liquid volume [ 3 , 4 ], and the effects of starvation and diabetes on glucose transport [ 1 , 5 ]. (ersjournals.com)
Transporter1
  • 10 SGLT2i prevent reabsorption of glucose by blocking sodium-dependent glucose transporter 2 in the proximal convoluted tubule. (uspharmacist.com)
Urinary1
Decreases1
Intestinal absorption of glucose1
Plasma glucose2
Empagliflozin2
  • reported that chronic administration of empagliflozin enhanced ATP production in the heart of db/db mice, although they argued that this was due to an increase in glucose and fatty acid oxidation rather than the utilization of ketone bodies 8 . (nature.com)
  • The so-called "gliflozines," such as ertugliflozin, empagliflozin, dapagliflozin, and canagliflozin, have demonstrated beneficial effects besides their glucose- and hemoglobin A1c (HbA1c) lowering impact. (frontiersin.org)
Concentrations7
  • Here, we consider a newly identified role for pulmonary glucose transport in maintaining low airway surface liquid (ASL) glucose concentrations and propose that this contributes to lung defence against infection. (ersjournals.com)
  • These processes vary between species but universally maintain ASL glucose at 3-20-fold lower concentrations than plasma. (ersjournals.com)
  • ASL glucose concentrations are increased in respiratory disease and by hyperglycaemia. (ersjournals.com)
  • ASL glucose concentrations are the net result of diffusion of glucose from blood and interstitial fluid across the respiratory epithelium into the ASL, and removal of glucose from ASL by epithelial glucose transport processes. (ersjournals.com)
  • Current model of the mechanisms controlling glucose concentrations in the surface liquid lining the airway and distal lung epithelium. (ersjournals.com)
  • 1 Simply put, EDKA is DKA in which normal glucose concentrations are present. (uspharmacist.com)
  • Physicians now recognize that zinc supplementation can reduce the incidence and severity of diarrheal disease, and an ORS of reduced osmolarity (i.e., proportionally reduced concentrations of sodium and glucose) has been developed for global use. (cdc.gov)
Uptake1
  • Glucose removal is determined by cellular glucose uptake and metabolism ( fig. 1 ) [ 4 , 12 - 14 ]. (ersjournals.com)
Body's1
  • Glucose is the primary source of energy for the body's cells and is gotten from the food we eat. (spagati.com)
Renal glucose1
Reduce blood glucose1
Reduces blood glucose1
  • Dietary Phloridzin reduces blood glucose levels and reverses Sglt1 expression in the small intestine in Streptozotocin-induced diabetic mice. (aphios.com)
Distal1
Absorption2
Type 2 diabet2
  • Dapagliflozin (Farxiga) is an oral medication used to improve glycemia ( blood glucose ) control in patients with type 2 diabetes . (medicinenet.com)
  • Patients with type 2 diabetes struggle managing their blood sugar, and nearly half of adults with type 2 diabetes do not achieve recommended levels of glucose control, increasing their risks for potentially life-threatening complications," said Richard Aguilar*, M.D., Medical Director, Diabetes Nation, LLC and Diabetes Care Foundation, a non-profit organization committed to improving diabetes care. (jnj.com)
Sodium and glucose1
Levels3
  • A fasting glucose test is a test of your blood sugar levels taken in the morning before you have eaten. (webmd.com)
  • An oral glucose tolerance test (OGTT) entails drinking a beverage containing glucose and then having your blood glucose levels checked every 30 to 60 minutes for up to 3 hours. (webmd.com)
  • Soluble fibres have been shown to help normalise serum cholesterol levels by binding directly to cholesterol, decreasing the chance of reabsorption and promoting excretion. (bbcgoodfood.com)
Metabolism1
  • Glucose is removed from ASL in proximal airways via facilitative glucose transporters, down a concentration gradient generated by intracellular glucose metabolism. (ersjournals.com)
Postprandial1
Transporters1
Medications1
  • Although a large number of the issues that cause the need for an amputation involve, there are those that are related to the management of glucose in the body and unknown risks of certain medications. (advocacyforpatients.org)
Substances1
  • It is not all substances that are reabsorbed, so we call this process selective reabsorption . (albertteen.com)
Tolerance2